Takeda Pharmaceutical
TAK
#491
Rank
NZ$81.93 B
Marketcap
NZ$24.62
Share price
0.28%
Change (1 day)
7.04%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : NZ$8.65 Billion

According to Takeda Pharmaceutical's latest financial reports the company has NZ$8.65 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31NZ$4.77 B-8.55%
2024-03-31NZ$5.21 B-21.31%
2023-03-31NZ$6.63 B-36.03%
2022-03-31NZ$10.36 B-20.07%
2021-03-31NZ$12.96 B26.96%
2020-03-31NZ$10.21 B6.64%
2019-03-31NZ$9.57 B96.36%
2018-03-31NZ$4.87 B1.18%
2017-03-31NZ$4.82 B-33%
2016-03-31NZ$7.19 B-9.89%
2015-03-31NZ$7.98 B-15.99%
2014-03-31NZ$9.50 B33.58%
2013-03-31NZ$7.11 B5.08%
2012-03-31NZ$6.76 B-50.9%
2011-03-31NZ$13.78 B3.68%
2010-03-31NZ$13.29 B-1.97%
2009-03-31NZ$13.56 B-33.8%
2008-03-31NZ$20.48 B-4.08%
2007-03-31NZ$21.36 B-18.54%
2006-03-31NZ$26.22 B31.94%
2005-03-31NZ$19.87 B4.44%
2004-03-31NZ$19.02 B8.74%
2003-03-31NZ$17.50 B16.02%
2002-03-31NZ$15.08 B4.86%
2001-03-31NZ$14.38 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$32.13 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$18.09 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$25.94 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.88 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ$2.14 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.36 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$16.35 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$7.69 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$31.53 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA